These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 26498233)

  • 1. Open-label study of the efficacy and safety of intravenous ferric carboxymaltose in pregnant women with restless legs syndrome.
    Schneider J; Krafft A; Manconi M; Hübner A; Baumann C; Werth E; Gyr T; Bassetti C
    Sleep Med; 2015 Nov; 16(11):1342-1347. PubMed ID: 26498233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, placebo-controlled trial of ferric carboxymaltose in restless legs syndrome patients with iron deficiency anemia.
    Bae H; Cho YW; Kim KT; Allen RP; Earley CJ
    Sleep Med; 2021 Aug; 84():179-186. PubMed ID: 34157632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial.
    Allen RP; Adler CH; Du W; Butcher A; Bregman DB; Earley CJ
    Sleep Med; 2011 Oct; 12(9):906-13. PubMed ID: 21978726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the response to intravenous iron in restless legs syndrome: an observational study.
    Hornyak M; Scholz H; Kiemen A; Kassubek J
    Sleep Med; 2012 Jun; 13(6):732-5. PubMed ID: 22503006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy and safety of intravenous ferric carboxymaltose for treatment of restless legs syndrome: a multicenter, randomized, placebo-controlled clinical trial.
    Earley CJ; García-Borreguero D; Falone M; Winkelman JW
    Sleep; 2024 Jul; 47(7):. PubMed ID: 38625730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of ferric carboxymaltose (FCM) 500 mg dose for the treatment of Restless Legs Syndrome.
    Cho YW; Allen RP; Earley CJ
    Sleep Med; 2018 Feb; 42():7-12. PubMed ID: 29458749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferric carboxymaltose in patients with restless legs syndrome and nonanemic iron deficiency: A randomized trial.
    Trenkwalder C; Winkelmann J; Oertel W; Virgin G; Roubert B; Mezzacasa A;
    Mov Disord; 2017 Oct; 32(10):1478-1482. PubMed ID: 28643901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP).
    Breymann C; Milman N; Mezzacasa A; Bernard R; Dudenhausen J;
    J Perinat Med; 2017 May; 45(4):443-453. PubMed ID: 27278921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient characteristics predicting responses to intravenous ferric carboxymaltose treatment of restless legs syndrome.
    Park HR; Choi SJ; Joo EY; Allen RP
    Sleep Med; 2020 Nov; 75():81-87. PubMed ID: 32853922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of ferric carboxymaltose treatment in patients with restless legs syndrome.
    Cho YW; Allen RP; Earley CJ
    Sleep Med; 2016 Sep; 25():16-23. PubMed ID: 27823710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous iron sucrose for restless legs syndrome in pregnant women with low serum ferritin.
    Vadasz D; Ries V; Oertel WH
    Sleep Med; 2013 Nov; 14(11):1214-6. PubMed ID: 24012019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous iron administration in restless legs syndrome : An observational study in geriatric patients.
    Lieske B; Becker I; Schulz RJ; Polidori MC; Kassubek J; Roehrig G
    Z Gerontol Geriatr; 2016 Oct; 49(7):626-631. PubMed ID: 26597718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy.
    Froessler B; Gajic T; Dekker G; Hodyl NA
    Arch Gynecol Obstet; 2018 Jul; 298(1):75-82. PubMed ID: 29740690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy.
    Khalafallah AA; Hyppa A; Chuang A; Hanna F; Wilson E; Kwok C; Yan C; Gray Z; Mathew R; Falloon P; Dennis A; Pavlov T; Allen JC
    Semin Hematol; 2018 Oct; 55(4):223-234. PubMed ID: 30502851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of ferric carboxymaltose versus ferrous sulfate for iron deficiency anemia during pregnancy: subgroup analysis of Korean women.
    Shim JY; Kim MY; Kim YJ; Lee Y; Lee JJ; Jun JK; Shin JC; Cho YK; Lee KY; Kim A; Song TB
    BMC Pregnancy Childbirth; 2018 Aug; 18(1):349. PubMed ID: 30153811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Intravenous Iron Sucrose in Hemodialysis Patients with Restless Legs Syndrome (RLS): A Randomized, Placebo-Controlled Study.
    Deng Y; Wu J; Jia Q
    Med Sci Monit; 2017 Mar; 23():1254-1260. PubMed ID: 28285317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy- randomised controlled trial.
    Jose A; Mahey R; Sharma JB; Bhatla N; Saxena R; Kalaivani M; Kriplani A
    BMC Pregnancy Childbirth; 2019 Feb; 19(1):54. PubMed ID: 30717690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia.
    Geisser P; Banké-Bochita J
    Arzneimittelforschung; 2010; 60(6a):362-72. PubMed ID: 20648928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy and safety of intravenous ferric carboxymaltose treatment of pediatric restless legs syndrome and periodic limb movement disorder.
    DelRosso LM; Ferri R; Chen ML; Kapoor V; Allen RP; Mogavero MP; Picchietti DL
    Sleep Med; 2021 Nov; 87():114-118. PubMed ID: 34562823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy and safety of intravenous ferric carboxymaltose treatment for restless legs symptoms and low serum ferritin in children with autism spectrum disorder.
    DelRosso LM; Reuter-Yuill LM; Cho Y; Ferri R; Mogavero MP; Picchietti DL
    Sleep Med; 2022 Dec; 100():488-493. PubMed ID: 36265207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.